Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea-Reference-Cited by-同舟云学术

Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea

Published:2018-02-15 Issue:1 Volume:16 Page:
ISSN:1478-7547
Container-title:Cost Effectiveness and Resource Allocation
language:en
Short-container-title:Cost Eff Resour Alloc

Author:

Lee Donghoon,Shin Hyun-Young,Park Sang Min

Funder

Korea Centers for Disease Control & Prevention

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12962-018-0088-9.pdf

Reference58 articles.

1. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49:S45–55.

2. Chae HB, Kim JH, Kim JK, Yim HJ. Current status of liver diseases in Korea: hepatitis B. Clin Mol Hepatol. 2009;15(60):13–24.

3. Cheon JH, Park JW, Park WK, et al. The Clinical Report of 1078 cases of Hepatocellular carcinomas: National Cancer Center Experience. Clin Mol Hepatol. 2004;10(4):288–97.

4. Kim SR, Kudo M, Hino O, Han KH, Chung YH, Lee HS. Epidemiology of Hepatocellular carcinoma in Japan and Korea. Oncology. 2008;75:13–6.

5. Sim JG, Seo JK, Suh SJ. Prevalence and its changes of hepatitis B viral markers from 1988 to 1993 in Korean Children. Korean J Pediatr. 1995;38(11):1535–9.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Universal Hepatitis B Antibody Screening and Vaccination in Pregnancy;Obstetrics & Gynecology;2022-02-02

2. Cost-Effectiveness Analysis of Active Surveillance Compared to Early Surgery in Small Papillary Thyroid Cancer: A Systemic Review;Cancer Management and Research;2021-08

3. Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses;PharmacoEconomics - Open;2021-05-04

4. Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis;Vaccine;2021-05

5. A global investment framework for the elimination of hepatitis B;Journal of Hepatology;2021-03